• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约旦叙利亚难民中视网膜母细胞瘤的临床表现及治疗结果

Presentation and management outcomes of Retinoblastoma among Syrian refugees in Jordan.

作者信息

Yousef Yacoub A, Abu Salim Qusai F, Mohammad Mona, Jaradat Imad, Mehyar Mustafa, AlJabari Reem, Al-Habahbeh Omar, Saboubeh Khalid, Halalsheh Hadeel, Khzouz Jakub, Shawagfeh Munir, Sultan Iyad, AlMasri Mahmoud, Al-Nawaiseh Ibrahim, Al-Hussaini Maysa, Mansour Asem

机构信息

Department of Surgery, King Hussein Cancer Centre (KHCC), Amman, Jordan.

Department Radiation Oncology, King Hussein Cancer Centre (KHCC), Amman, Jordan.

出版信息

Front Oncol. 2023 Jan 13;12:1056963. doi: 10.3389/fonc.2022.1056963. eCollection 2022.

DOI:10.3389/fonc.2022.1056963
PMID:36713556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9880551/
Abstract

PURPOSE

The humanitarian crisis in Syria has had a profound impact on the entire region. In this study, we report the patterns of presentation and management outcomes of Syrian patients with Retinoblastoma (Rb) treated at a single tertiary cancer center in Jordan.

METHODS AND MATERIALS

This is a retrospective comparative study of Syrian refugees and Jordanian citizens who had Rb between 2011 and 2020. Collected data included patient demographics, presentation, tumor stage, treatment modalities, eye salvage rate, metastasis, and mortality.

RESULTS

Thirty Syrian refugees (16 (53%) had bilateral disease) and 124 Jordanian citizens (51(41%) had bilateral disease) were diagnosed with Rb during this period. The median age at diagnosis for refugees was 10 and 32 months for patients with bilateral and unilateral Rb consecutively, compared to 6 and 28 months for citizens. The median lag time between signs of disease and initiation of treatment was 3 months for refugees, compared to 1 month for citizens.Refugees were more likely to present with a more advanced stage (p=0.046). Out of 46 affected eyes in refugees; 32 (70%) eyes were group D or E, while out of 175 affected eyes among citizens; 98 (56%) eyes were group D or E. Therefore, refugees with Rb were more likely to mandate primary enucleation (48%) compared to citizens (25%) (p=0.003). However, out of 24 eyes among refugees who received conservative therapy, 15 (62%) eyes were successfully salvaged, while out of 131 affected eyes among citizens who received conservative therapy, 105 (80%) eyes were successfully salvaged (p=0.06). Two (7%) of the refugees and four (3.2%) of the citizens with Rb died from metastasis.

CONCLUSION

Syrian refugees with Rb presented with more advanced disease due to delay in diagnosis and referral that increased the treatment burden by decreasing the chance for eye globe salvage. However, patients who received the timely intervention had a similar outcome to citizens with Rb; probably a reflection of the management of all patients at a single specialized center. We advocate for the timely referral of refugees with this rare life-threatening tumor to a specialized cancer center for the best possible outcome.

摘要

目的

叙利亚的人道主义危机对整个地区产生了深远影响。在本研究中,我们报告了在约旦一家单一的三级癌症中心接受治疗的叙利亚视网膜母细胞瘤(Rb)患者的临床表现模式和治疗结果。

方法和材料

这是一项对2011年至2020年间患有Rb的叙利亚难民和约旦公民的回顾性比较研究。收集的数据包括患者人口统计学信息、临床表现、肿瘤分期、治疗方式、眼球挽救率、转移情况和死亡率。

结果

在此期间,30名叙利亚难民(16名(53%)患有双侧疾病)和124名约旦公民(51名(41%)患有双侧疾病)被诊断患有Rb。难民中双侧和单侧Rb患者的诊断中位年龄分别为10个月和32个月,而公民分别为6个月和28个月。难民从出现疾病症状到开始治疗的中位延迟时间为3个月,而公民为1个月。难民更有可能表现为疾病分期更晚(p = 0.046)。在难民的46只患眼中,32只(70%)为D组或E组,而在公民的175只患眼中,98只(56%)为D组或E组。因此,与公民(25%)相比,患有Rb的难民更有可能接受一期眼球摘除术(48%)(p = 0.003)。然而,在接受保守治疗的难民的24只眼中,15只(62%)眼球成功挽救,而在接受保守治疗的公民的131只患眼中,105只(80%)眼球成功挽救(p = 0.06)。两名(7%)患有Rb的难民和四名(3.2%)患有Rb的公民死于转移。

结论

患有Rb的叙利亚难民由于诊断和转诊延迟,表现为疾病更晚期,这通过降低眼球挽救机会增加了治疗负担。然而,接受及时干预的患者与患有Rb的公民有相似的结果;这可能反映了在单一专业中心对所有患者的管理情况。我们主张将患有这种罕见的危及生命肿瘤的难民及时转诊至专业癌症中心,以获得最佳可能结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/9880551/61ce78183d29/fonc-12-1056963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/9880551/61ce78183d29/fonc-12-1056963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/9880551/61ce78183d29/fonc-12-1056963-g001.jpg

相似文献

1
Presentation and management outcomes of Retinoblastoma among Syrian refugees in Jordan.约旦叙利亚难民中视网膜母细胞瘤的临床表现及治疗结果
Front Oncol. 2023 Jan 13;12:1056963. doi: 10.3389/fonc.2022.1056963. eCollection 2022.
2
Bilateral enucleation for retinoblastoma: A study of 14 patients.视网膜母细胞瘤的双侧眼球摘除术:14例患者的研究
Oman J Ophthalmol. 2022 Jun 29;15(2):188-192. doi: 10.4103/ojo.ojo_272_21. eCollection 2022 May-Aug.
3
Causes of death and survival analysis for patients with retinoblastoma in Jordan.约旦视网膜母细胞瘤患者的死因及生存分析
Front Med (Lausanne). 2023 Sep 4;10:1244308. doi: 10.3389/fmed.2023.1244308. eCollection 2023.
4
Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020).约旦的视网膜母细胞瘤和葡萄膜黑色素瘤:发病率、人口统计学和生存情况(2011-2020 年)。
Ophthalmic Genet. 2023 Apr;44(2):119-126. doi: 10.1080/13816810.2022.2090008. Epub 2022 Jul 17.
5
A 20-year audit of retinoblastoma treatment outcomes.20 年视网膜母细胞瘤治疗结果回顾性分析。
Eye (Lond). 2020 Oct;34(10):1916-1924. doi: 10.1038/s41433-020-0898-9. Epub 2020 May 6.
6
Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy.既往仅接受全身化疗而未接受局部治疗的视网膜母细胞瘤患者的治疗结局。
Oman J Ophthalmol. 2017 May-Aug;10(2):70-75. doi: 10.4103/ojo.OJO_225_2015.
7
Health service access and utilization among Syrian refugees in Jordan.约旦境内叙利亚难民的医疗服务获取与利用情况。
Int J Equity Health. 2016 Jul 14;15(1):108. doi: 10.1186/s12939-016-0399-4.
8
The Impact of Tumor Laterality (Unilateral vs. Bilateral) on Presentation and Management Outcome in Patients with Retinoblastoma.肿瘤单侧性(单侧与双侧)对视网膜母细胞瘤患者临床表现及治疗结果的影响
J Clin Med. 2024 Apr 8;13(7):2146. doi: 10.3390/jcm13072146.
9
Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study.叙利亚难民中乳腺癌的晚期表现和治疗不足:一项回顾性研究。
J Int Med Res. 2021 May;49(5):3000605211018448. doi: 10.1177/03000605211018448.
10
Health needs and priorities of Syrian refugees in camps and urban settings in Jordan: perspectives of refugees and health care providers.约旦难民营和城市中叙利亚难民的健康需求和重点:难民和卫生保健提供者的观点。
East Mediterr Health J. 2018 Jun 10;24(3):243-253. doi: 10.26719/2018.24.3.243.

引用本文的文献

1
Retinoblastoma programme outcome over a 10-year period in Lebanon: assessment of potential impact of the pandemic and economic crisis.黎巴嫩10年期视网膜母细胞瘤项目成果:评估大流行和经济危机的潜在影响
Eye (Lond). 2025 Mar;39(4):748-754. doi: 10.1038/s41433-024-03465-8. Epub 2024 Nov 19.
2
Causes of death and survival analysis for patients with retinoblastoma in Jordan.约旦视网膜母细胞瘤患者的死因及生存分析
Front Med (Lausanne). 2023 Sep 4;10:1244308. doi: 10.3389/fmed.2023.1244308. eCollection 2023.

本文引用的文献

1
Incidence of retinoblastoma in children and adolescents in Brazil: A population-based study.巴西儿童和青少年视网膜母细胞瘤的发病率:一项基于人群的研究。
Front Pediatr. 2022 Nov 23;10:1048792. doi: 10.3389/fped.2022.1048792. eCollection 2022.
2
Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020).约旦的视网膜母细胞瘤和葡萄膜黑色素瘤:发病率、人口统计学和生存情况(2011-2020 年)。
Ophthalmic Genet. 2023 Apr;44(2):119-126. doi: 10.1080/13816810.2022.2090008. Epub 2022 Jul 17.
3
Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy.
提高医学生对视网膜母细胞瘤的认识:一项实用策略。
Clin Ophthalmol. 2022 Jun 7;16:1807-1814. doi: 10.2147/OPTH.S355876. eCollection 2022.
4
Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.基于临床表现和晚期眼内视网膜母细胞瘤治疗的转移性死亡:一项基于多中心登记的研究。
Ophthalmology. 2022 Aug;129(8):933-945. doi: 10.1016/j.ophtha.2022.04.022. Epub 2022 Apr 30.
5
A Proposal for Future Modifications on Clinical TNM Staging System of Retinoblastoma Based on the American Joint Committee on Cancer Staging Manual, 7 and 8 Editions.基于美国癌症联合委员会第7版和第8版分期手册对视网膜母细胞瘤临床TNM分期系统未来修改的建议
J Cancer. 2022 Feb 7;13(4):1336-1345. doi: 10.7150/jca.61005. eCollection 2022.
6
Epidemiology and Incidence of Retinoblastoma in the Middle East: A Nationwide Study in Lebanon.中东地区视网膜母细胞瘤的流行病学与发病率:黎巴嫩的一项全国性研究
Cureus. 2021 Oct 12;13(10):e18696. doi: 10.7759/cureus.18696. eCollection 2021 Oct.
7
Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study.叙利亚难民中乳腺癌的晚期表现和治疗不足:一项回顾性研究。
J Int Med Res. 2021 May;49(5):3000605211018448. doi: 10.1177/03000605211018448.
8
Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries.视网膜母细胞瘤首发症状出现至治疗的延迟时间:一项对来自10个国家的692例患者的国际合作研究。
Cancers (Basel). 2021 Apr 19;13(8):1956. doi: 10.3390/cancers13081956.
9
The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.第八版临床 TNM 分期系统对眼内视网膜母细胞瘤全身化疗和局部治疗后保眼可能性的预测价值。
J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e841-e847. doi: 10.1097/MPH.0000000000002144.
10
Global Retinoblastoma Treatment Outcomes: Association with National Income Level.全球视网膜母细胞瘤治疗结果:与国民收入水平的关联。
Ophthalmology. 2021 May;128(5):740-753. doi: 10.1016/j.ophtha.2020.09.032. Epub 2020 Sep 29.